Brainstem lesions are associated with sleep apnea in multiple sclerosis by Levit, Elle et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Publications by UMMS Authors 
2020-11-05 
Brainstem lesions are associated with sleep apnea in multiple 
sclerosis 
Elle Levit 
Beth Israel Deaconess Medical Center 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Immune System Diseases Commons, Nervous System Diseases Commons, Neurology 
Commons, and the Respiratory Tract Diseases Commons 
Repository Citation 
Levit E, Bouley A, Baber U, Djonlagic I, Sloane JA. (2020). Brainstem lesions are associated with sleep 
apnea in multiple sclerosis. Open Access Publications by UMMS Authors. https://doi.org/10.1177/
2055217320967955. Retrieved from https://escholarship.umassmed.edu/oapubs/4473 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access 
Publications by UMMS Authors by an authorized administrator of eScholarship@UMMS. For more information, 
please contact Lisa.Palmer@umassmed.edu. 
Original Research Paper
Brainstem lesions are associated with sleep apnea
in multiple sclerosis
Elle Levit, Andrew Bouley, Ursela Baber, Ina Djonlagic and Jacob A Sloane
Abstract
Background: Studies linking MRI findings in MS patients with obstructive sleep apnea severity
are limited.
Objective: We conducted a retrospective study to assess MRI abnormalities associated with obstructive
sleep apnea (OSA) in patients with multiple sclerosis (MS).
Methods: We performed retrospective chart review of 65 patients with multiple sclerosis who had
undergone polysomnography (PSG) for fatigue as well as brain MRI. We measured the number of
lesions in the brainstem and calculated the standardized third ventricular width (sTVW) as a measure of
brain atrophy, and subsequently performed correlation analyses of the apnea-hypopnea index (AHI) with
brainstem lesion location, sTVW, and Expanded Disability Status Scale (EDSS).
Results: MS Patients with OSA were significantly older and had a higher body mass index (BMI) and
higher AHI measures than patients without OSA. After adjustment for covariates, significant associa-
tions were found between AHI and lesion burden in the midbrain (p< 0.01) and pons (p¼ 0.05), but not
medulla.
Conclusions: Midbrain and pontine lesions burden correlated with AHI, suggesting MS lesion location
could contribute to development of OSA.
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Introduction
OSA is a common problem in the general
population with an estimated prevalence of
2–16%,1 while OSA prevalence in MS patients
appears to be much higher2–4 OSA causes repeated
arousals, which can contribute to neurocognitive
complaints, decreased quality of life, and fatigue.5,6
Fatigue is a common, multifactorial symptom in MS,
affecting up to 90% of MS patients, and OSA may
contribute to fatigue given its prevalence in MS
patients.7
MS patients with radiographic evidence of general
brainstem involvement have significantly higher
AHI compared to those without,2 suggesting that
regional brainstem dysfunction may contribute to
the severity of OSA.8
OSA has other cerebral implications such as
increased atrophy of gray and white matter.9,10
Brain atrophy is also seen in MS and is a marker
of disease progression.11,12 Anecdotal reports show
that patients with both conditions have more brain
atrophy than with MS alone.13
Our objectives were to refine radiographic localiza-
tion of MS lesions that associate with OSA in MS
patients. Given brainstem control of the upper
airway musculature, arousals, and loop gain manage-
ment,14–16 we hypothesize demyelinating lesions in
various brainstem regions may predispose MS
patients to OSA. Additionally, we have begun to
explore the link between OSA and brain atrophy,
and whether this could play a role in declining func-
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Methods
Subjects: 65 patients with MS from the Beth Israel
Deaconess Medical Center (BIDMC) MS Clinic who
had undergone either in-lab polysomnography (PSG)
or home PSG for a chief complaint of fatigue were
included in our study. 23 patients had undergone home
PSG and 42 had an in-lab PSG. Inclusion criteria were
diagnosis of MS, age 18 or older, and presence of a
sleep study and brain MRI. Other serious neurological
disorders were exclusionary including stroke, brain
tumor, or parkinsonism. Baseline characteristics
including age at onset of MS, gender, age at sleep
study, duration of disease from onset to sleep study,
type of MS, EDSS, and BMI at time of sleep study
were determined through chart review. Centrally
acting medicines were present but balanced between
groups. Data collection and analysis was approved by
the BIDMC Institutional Review Board.
MRI Variables: An MRI obtained within one year of
sleep study was available for all patients included in
the study. Two independent neurologists reviewed
MRI data and counted the number of cerebral and
brainstem lesions and mean values were calculated.
Third ventricular width (TVW) was measured from
the axial T1-weighted scan on which this structure
was maximally visible in its antero-posterior extent.
Standardized third ventricular width (sTVW) was
then calculated by dividing by total brain width mea-
sured at the same level, a validated measure of brain
atrophy used for monitoring disease progression in
MS.17 We were unable to used computerized volu-
metric measurement tools due to diverse MRI prac-
tices for the studied patients.
Polysomnography Data: We reviewed in-lab and
home PSG reports from BIDMC Sleep Clinic and
outside sleep centers. For in-lab sleep studies, over-
night PSG had been performed with a six-channel
electroencephalogram, electrocardiogram (ECG)
and oxyhemoglobin saturation by pulse oximetry.
For home sleep studies, patients underwent over-
night PSG with Alice NightOne type 3 home sleep
testing device, with recording of oxyhemoglobin sat-
uration and heart rate by pulse oximetry. Results of
both types of sleep studies were interpreted by board
certified sleep medicine physicians following the
American Academy of Sleep Medicine standards
apnea and hypopnea scoring. Diagnosis of obstruc-
tive sleep apnea required five or more obstructive
respiratory events per hour of sleep with associated
fatigue or snoring, or greater than 14 obstructive
respiratory events per hour regardless of other symp-
toms. Apnea was defined as cessation of airflow
lasting for at least 10 seconds, while hypopnea was
defined as a reduction of airflow of 30% or more
lasting for at least 10 seconds. AHI was defined as
the sum of apneas and hypopneas and dividing by
the sum of total sleep time in hours. The apnea
hypopnea 4% index (AHI4%) was defined as the
total number of apneas and hypopneas with greater
than or equal to 4% SpO2 desaturations plus the
number of apneas per hour of sleep, which is the
current guideline from Medicare for coverage of
CPAP. Variables evaluated from sleep study includ-
ed AHI, AHI4%, and central apnea index (CAI).
Data were collected at time of sleep study, so as to
include only patients not treated for OSA.
Statistical Analysis: Statistical tests were performed
using R-Studio statistics software.18 Tests were
2-sided with the level of statistical significance set
at 0.05. No mathematical correction was made for
multiple comparisons. All of the continuous quanti-
tative variables were presented as mean values with
standard deviation reported. The differences in con-
tinuous variables between patients with and without
OSA were assessed by Student’s t-test. Linear cor-
relations were applied to further evaluate factors that
may affect AHI after controlling for independent
risk factors for obstructive sleep apnea, including
age, male gender and BMI. We also controlled for
risk factors for brainstem lesions, including MS dis-
ease duration, smoking, and hypertension. Linear
correlations were also performed between AHI and
sTVW, controlling for age, male gender, BMI, MS
disease duration, smoking, and hypertension.
Results
Baseline data: Baseline characteristics for MS
patients with OSA and MS patients without OSA
are shown in Table 1. Sixty-five subjects with MS
with complete PSG data and MRI were identified.
Thirty-six patients had OSA diagnosed via PSG, and
29 did not have OSA. No patients were diagnosed
with central sleep apnea. Four patients had second-
ary progressive MS (3 with sleep apnea and 1 with-
out), and the rest had relapsing remitting MS. No
significant differences between subjects with and
without OSA emerged for female gender, age at
onset of MS, the number of years between onset of
MS symptoms and initial PSG, smoking status,
and depression (Table 1). Restless leg syndrome
was virtually absent from this patient population.
Significant differences between age and BMI at
time of sleep test were identified, with OSA patients
being both older and with higher BMIs than those
without OSA. There was also a significant positive
Medical Center, Boston,
USA
Multiple Sclerosis Journal—Experimental, Translational and Clinical
2 www.sagepub.com/msjetc
association between the presence of OSA and EDSS
as well as hypertension. We also observed a signif-
icant correlation between the presence of OSA and
sTVW, a measure of brain atrophy.
Sleep Measures: The mean AHI was significantly
higher in MS patients with OSA compared to those
without (p< 0.01), as was the AHI4% (p< 0.01)
(Table 2). There was no significant difference
found in regard to the number of central apneas
and hypopneas in these patient populations.
Maximum O2 desaturation was significantly lower
in those MS patients with OSA.
Univariate and Multivariate Analyses: Univariate
analysis was notable for a significantly higher
number of average lesions in the pons when compar-
ing patients with and without OSA. There was no
significant difference found in the number of lesions
in the midbrain and medulla in patients with and
without OSA (Table 3). Linear correlation analyses
were performed to determine any associations
between AHI and location of brainstem lesions.
After controlling for known OSA risk factors of
age, gender, BMI, as well as disease duration, hyper-
tension, and smoking status, there were significant
positive associations between AHI and average
number of lesions measured in the midbrain
(p< 0.01), pons (p< 0.01), and infratentorial lesions
(p< 0.01) (Table 4). No significant association with
number of medullary lesions was seen. We found no
correlations with numbers of cerebral lesions,




MS patients with OSA
(n¼ 36) p-Value
Age at PSG, mean (standard error) 41.4 (1.9) 48.2 (1.7) 0.01
Age at onset, mean (standard error) 31.7 (1.4) 34.5 (1.6) 0.18
Years from onset to sleep test,
mean (standard error)
9.9 (1.7) 14.0 (1.6) 0.08
Female, n (%) 26 (90%) 25 (69%) 0.07
BMI, kg/m2, mean (standard error) 27.8 (0.8) 32.7 (1.2) <0.01
Hypertension, n (%) 2 (6.9%) 10 (27.8%) 0.05
Depression, n (%) 11 (37.9%) 9 (25.0%) 0.29
Ever smokers, n (%) 11 (37.9%) 13 (36.1%) 1.0
Current smokers, n (%) 5 (17.2%) 5 (13.9%) 0.74
EDSS, mean (standard error) 2.2 (0.2) 3.1 (0.3) 0.02
sTVW, mean (standard error) 0.028 (0.011) 0.040 (0.014) <0.01
Legend: Abbreviations: MS¼multiple sclerosis; OSA¼ obstructive sleep apnea; BMI¼ body mass index;
EDSS¼Expanded Disability Status Scale; sTVW¼ standardized third ventricular width. p-values calculated using
Student’s T-test or Fisher exact test, p  0.05.








AHI, mean (standard error) 3.5 (0.6) 28.2 (4.3) <0.01
AHI4%, mean (standard error) 1.1 (0.9) 11.9 (2.4) <0.01
CAI, mean (standard error) 0.41 (0.22) 0.94 (0.24) 0.11
Maximum O2 desaturation,
mean (standard error)
90.7 (0.5) 84.8 (0.8) <0.01
Legend: Abbreviations: MS¼multiple sclerosis; OSA¼ obstructive sleep apnea; AHI¼ apnea hypopnea index;
AHI4%¼ apnea hypopnea index with 4% or greater desaturation; CAI¼ central apnea index; O2 nadir¼maximum O2
desaturation. p-values calculated using Student’s T-test, p 0.05.
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including lesions in specific lobar distributions, or in
periventricular or juxtacortical distributions.
There was no significant correlation between BMI
and the average number of brainstem lesions in the
midbrain, pons, medulla, and infratentorial lesions.
In addition, no association was observed between
maximum oxygen desaturation and lesion burden
in the midbrain, pons, and medulla (data not
shown). After adjusting for covariates, sTVW or
EDSS did not correlate with either AHI or maximum
oxygen desaturation (Table 4).
Data availability statement
Data not provided in the article because of space
limitations is stored in de-identified format and is
available at the request of any qualified investigators
for purposes of replicating procedures and results.
Discussion
OSA is frequently seen in MS patients and could
contribute to fatigue, a common multifactorial com-
plaint of many MS patients. Currently it is unknown
whether OSA develops specifically due to MS dis-
ease activity or due to other established factors such
as obesity, inactivity, and/or age. Since we do not
yet have a prospective analysis of any interplay
between OSA and MS, we first wanted to determine
correlations between aspects of radiographic MS dis-
ease and OSA.
In this study, we aimed to determine if brainstem
lesion location could predict severity of OSA. We
found that MS patients with obstructive sleep apnea
had an increasing AHI in relation to brainstem lesion
number when controlled for age, gender, and BMI.
Specifically, we found a correlation with AHI and
lesions in the midbrain and pons, but not the medul-
la. This expands upon previous data that MS patients
with brainstem involvement have significantly
higher AHI,8 highlighting the importance of specific
lesion location in modulating sleep apnea.
OSA is a heterogenous disorder influenced by upper
airway patency but also other factors, including gen-
ioglossus responsiveness, arousal threshold, and loop
gain.15 Therefore, brainstem dysfunction could play
a role in OSA development and severity. Our find-
ings may shed light on neuroanatomic mechanisms
and possible dysfunction contributing to OSA in MS.
Sleep is promoted by the ventrolateral preoptic
nucleus (VLPO) and median preoptic nucleus
(MnPO) in the hypothalamus, as well as the parafa-
cial zone in the medulla.19 Wakefulness in OSA may
be mediated by the parabrachial (PB) complex in the
dorsolateral pons, which receives signals from the
medullary nuclei, including nucleus of the solitary
tract (NTS), pre-B€otzinger Complex and the









Number of midbrain lesions,
mean (standard error)
0.10 (0.05) 0.22 (0.06) 0.18
Number of pontine lesions,
mean (standard error)
0.25 (0.07) 0.59 (0.13) 0.03
Number of medullary lesions,
mean (standard error)
0.03 (0.02) 0.07 (0.03) 0.21
p-values calculated using Student’s T-test, p 0.05.
Table 4. Regression analyses of AHI and location
of demyelinating lesions, sTVW, and EDSS after
controlling for age, gender, BMI, disease duration,
hypertension, and smoking history.
Variable correlated with AHI p-Value R2
Midbrain lesions <0.01 0.49
Pontine lesions 0.05 0.40
Medullary lesions 0.62 0.37
Infratentorial lesions <0.01 0.46
sTVW 0.85 0.37
EDSS 0.96 0.37
Abbreviations: AHI¼ apnea hypopnea index;
sTVW¼ standardized third ventricular width;
EDSS¼Expanded Disability Status Scale;
BMI¼Body Mass Index. R2 values are for model fit. p-
values calculated using regression analysis, p  0.05.
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retrotrapezoid nucleus (RTN)/parafacial respiratory
group (pFRG), which generate rhythm and respond
to hypercarbia.20–22 Output from the external lateral
PB subnuclei feeds back to the medulla, driving
increased respiratory rate in hypercapnia. The lateral
crescent PB subnuclei projects to more rostral tar-
gets involved in wakefulness through the midbrain.19
It is clear that a complex interplay of various brain-
stem nuclei coordinate maintenance of sleep or the
transition to wakefulness.
Interruption of these pathways, which could occur
through demyelination in MS, could in turn alter
the physiologic response to rising CO2 and re-
establishment of the airway through awakening,
manifesting clinically as an increase in AHI. As
observed in our study, lesions in the midbrain and
pons were associated with an increase in AHI. We
hypothesize this observation could be due to damage
of nuclei such as the PBlc and its projections, effec-
tively reducing the normal physiologic ventilatory
response to hypercapnia, thereby increasing AHI. It
is also possible that midbrain and pontine lesions
lower arousal threshold resulting in recurrent awak-
enings to reestablish the compromised upper airway,
and an increase in AHI.14–16
Brain atrophy has been described in OSA and is also
seen as a result of longstanding MS.10,11 In our
study, standardized third ventricular width was
used as a surrogate for overall brain atrophy and
did not have a significant relationship with AHI
after correcting for covariates. We feel this result
is inconclusive for many reasons, including small
study size and brain volume measurement method-
ology, and are aiming to conduct another study with
more sophisticated tools.
Among potential study limitations, the small sample
size, low lesion frequency, and retrospective and
observational, cross-sectional design preclude con-
clusions on causation. Our overall MRI related
methodology was not automated both in terms of
lesion counts and volumetric measurements.
Computerized metrics of MRI data were not possible
since MRIs were generated by different sites and at
different times. We used a mix of home sleep studies
and in-lab PSGs, and home sleep studies are less
sensitive to detect milder forms of OSA. However,
we found no differences between groups in study
types performed. Finally, we were surprised to
have only 4 progressive MS patients in our study.
This reduced EDSS averages, and may have made
statistical analyses with this metric less robust.
Our work suggests that brainstem lesion location in
MS patients could contribute to increased AHI and
the development of clinical OSA. Testing for OSA is
encouraged, since OSA is common in MS an may
develop in MS patients without classic risk factors
for OSA. Although unproven here, it is also possible
that aggressive treatment of MS may help avoid
development of OSA as a comorbidity. Further
work will be needed to prospectively determine the
effect of MS on OSA development, the role of OSA
in MS worsening and MS relapses, as well as to
determine possible interplay between OSA treatment
with MS outcomes.
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